Oct 27, 2020 | Government Investigations, Health Care, White Collar Crime
Earlier this year, a jury found Sylvia Hofstetter guilty of a Racketeer Influenced Corrupt Organization (“RICO”) conspiracy, two counts of drug conspiracy, money laundering, and maintaining a drug-involved premise for her role in operating pill mills in Florida and...
Oct 20, 2020 | Government Investigations, Health Care, White Collar Crime
The False Claims Act has long been considered one of the Department of Justice’s (“DOJ”) most powerful tools for preventing wrongdoing in the healthcare industry. However, the DOJ’s Antitrust Division has been actively investigating anti-competitive behavior in the...
Sep 11, 2020 | COVID-19 Related Law, Government Investigations, White Collar Crime
On September 10, Acting Assistant Attorney General Brian Rabbitt delivered remarks at the PPP Criminal Fraud Enforcement Action Press Conference. A written version of his remarks can be accessed here. The Paycheck Protection Program (PPP) was part of the CARES Act,...
Aug 31, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid, White Collar Crime
The federal Anti-Kickback Statute (AKS), at its core, prohibits offering, paying, soliciting, or receiving any remuneration in exchange for federal healthcare program referrals. AKS violations carry potential criminal penalties, as well as civil and administrative...
Aug 19, 2020 | Fraud Investigations, Government Investigations, White Collar Crime
Last week, the Criminal Division of the U.S. Department of Justice (DOJ) issued new guidance regarding enforcement of the Foreign Corrupt Practices Act (FCPA), wherein it addressed an inquiry by a United States investment advisor regarding its intent to pay a foreign...
Aug 13, 2020 | Fraud Investigations, Government Investigations, Health Care, White Collar Crime
On August 7, 2020, the U.S. Department of Justice (“DOJ”) announced the indictment of a psychiatrist and his office manager for allegedly importing and selling drugs not approved by the U.S. Food & Drug Administration (“FDA”). The DOJ alleges that for ten years,...
